Table 2. Summary of immunoconjugate peaks observed by ESI-MS.
Assignment | m/z a |
Trastuzumab | |
Light chain | 23 439 |
Heavy chain | 50 594 (50 757) |
Light-heavy chain | 74 031 (74 194) |
H3YM103-trastzumab | |
Light chain | 23 439 |
Light chain + H3YM103 | 24 360 |
Heavy chain | 50 594 (50 755) |
Heavy chain + H3YM103 | 51 519 (51 676) |
Heavy chain + 2(H3YM103) | 52 439 (52 596) |
Heavy chain + 3(H3YM103) | 53 356 (53 518) |
Light-heavy chain | 74 031 (74 194) |
Light-heavy chain + H3YM103 | 74 954 (75 118) |
Light-heavy chain + 2(H3YM103) | 75 877 (76 038) |
H3DFO-trastuzumab | |
Light chain + 1(H3DFO) | 24 151 |
Heavy chain + 3(H3DFO) | 52 730 (52 892) |
Light-heavy chain + 2(H3DFO) | 75 466 (75 617) |
a Signal in brackets due to additional hexose unit in variably glycosylated heavy chain.